HARNESS Trademark
Trademark Overview
On Monday, February 19, 2024, a trademark application was filed for HARNESS with the United States Patent and Trademark Office. The USPTO has given the HARNESS trademark a serial number of 79398079. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, March 14, 2025. This trademark is owned by Harness Therapeutics Limited. The HARNESS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, psychiatric disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, psychiatric disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents for medical use; DNA, RNA, oligonucleotides, polynucleotides for medical use; gene editing enzymes for medical use; medical preparations ...
Chemicals for scientific purposes; chemicals for use in scientific research; chemicals, enzymes, biological preparations in the nature of DNA and RNA for scientific research use; chemicals for scientific research use in the preparation and creation of DNA and RNA; enzymes for scientific research purposes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use
Scientific and technological services and research and design relating thereto namely scientific research services in the field of genomics; medical research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; chemical and biological analysis and research services; scientific research into DNA and RNA; research and development into the creation of DNA and RNA; research and development services in the manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; research, development, testing and analysis for scientific research purposes in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; scientific research in the field of molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene-editing services for scientific research purposes; DNA and RNA modelling services, namely, genetic mapping for scientific r...
General Information
| Serial Number | 79398079 |
| Word Mark | HARNESS |
| Filing Date | Monday, February 19, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Friday, March 14, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, psychiatric disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, psychiatric disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents for medical use; DNA, RNA, oligonucleotides, polynucleotides for medical use; gene editing enzymes for medical use; medical preparations containing therapeutic DNA and RNA, namely, nucleic and sequences for medical purposes; all of the foregoing excluding dietary and nutritional supplements |
| Goods and Services | Chemicals for scientific purposes; chemicals for use in scientific research; chemicals, enzymes, biological preparations in the nature of DNA and RNA for scientific research use; chemicals for scientific research use in the preparation and creation of DNA and RNA; enzymes for scientific research purposes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use |
| Goods and Services | Scientific and technological services and research and design relating thereto namely scientific research services in the field of genomics; medical research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; chemical and biological analysis and research services; scientific research into DNA and RNA; research and development into the creation of DNA and RNA; research and development services in the manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; research, development, testing and analysis for scientific research purposes in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; scientific research in the field of molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene-editing services for scientific research purposes; DNA and RNA modelling services, namely, genetic mapping for scientific research purposes; gene engineering services; research and development services in the creation of genome libraries and collections of biologicals including chemicals and compounds; research and development services in creating libraries and collections of normal and mutated genes; scientific services research relating to the discovery, preclinical and clinical development of therapeutic products, namely, therapeutic DNA and RNA; consultancy and advisory services relating to the aforesaid services |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Harness Therapeutics Limited |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 98 - Unknown |
| Address | GB |
| Party Name | Harness Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
Trademark Events
| Event Date | Event Description |
| Thursday, June 20, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, June 24, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, June 24, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, September 9, 2024 | ASSIGNED TO EXAMINER |
| Thursday, September 12, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, September 16, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, October 7, 2024 | REFUSAL PROCESSED BY IB |
| Saturday, November 30, 2024 | ASSIGNED TO EXAMINER |
| Friday, March 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 14, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, September 13, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, September 16, 2024 | REFUSAL PROCESSED BY MPU |
| Saturday, November 30, 2024 | ASSIGNED TO EXAMINER |
| Friday, March 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 19, 2025 | ASSIGNED TO EXAMINER |
| Friday, March 21, 2025 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
